TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

VALNEVA Déclaration d’actions et de droits de vote : 30 novembre 2025

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Valneva Se
VALNEVA Déclaration d’actions et de droits de vote : 30 novembre 2025

Valneva is consolidating its French operations at its Lyon site and finalizing R&D consolidation in Vienna. The company also reported positive Phase 2 results for its Lyme Disease vaccine candidate, showing sustained antibody levels and no safety concerns.

Insights
AAPL   negative

Part of the Magnificent Seven group that lost significant market value


VALN   positive

Positive Phase 2 vaccine trial results, strategic operational consolidation, and continued research and development efforts indicate company growth and progress